Serum CEA is not sensitive nor specific enough to identify CCA on its own since it can be elevated in benign illnesses, such as peptic ulcer disease, gastritis, diverticulitis, and liver disease, in addition to various primary gastrointestinal cancers. The gene discussed is CEACAM5; the disease is cholangiocarcinoma.